Oncologix Tech

Oncologix Tech EBIT per Share

Delisted·Sep 9, 2026

EBIT per Share of Oncologix Tech (OCLG) as of Oct 29, 2026.

EBIT per Share

-0.00USD

YoY

61.05%

Last updated:

EBIT per Share of Oncologix Tech is 2017 -0.00 USD. EBIT per Share of Oncologix Tech was 2016 -0.00 USD. It decreases by 61.05% lower compared to the previous year.

The Oncologix Tech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2010
-0.00 USD
Jan 1, 2011
-0.00 USD
Jan 1, 2012
-0.00 USD
Jan 1, 2013
-0.00 USD
Jan 1, 2014
-0.00 USD
Jan 1, 2015
-0.00 USD
Jan 1, 2016
-0.00 USD
Jan 1, 2017
-0.00 USD
The Oncologix Tech EBIT per Share history
YEAREBIT per ShareYoY
-0.00USD+61.05%
-0.00USD-8.63%
-0.00USD-82.25%
-0.00USD+18.41%
-0.00USD+60.38%
-0.00USD-39.58%
-0.00USD-7.84%
-0.00USD-79.02%
-0.02USD-4.35%
-0.02USD-94.27%
-0.35USD-12.19%
-0.40USD-99.39%
-66.05USD+11,905.17%
-0.55USD-0.22%
-0.55USD-45.78%
-1.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncologix Tech Stock analysis

What does Oncologix Tech do? Oncologix Tech, Inc. generates revenue through the operation and manufacture of medical device products. The company collaborates with manufacturers and stakeholders in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers. It reviews licenses and sublicense agreements with potential licensors and conducts research and due diligence on potential partners, joint-ventures, and acquisitions in the biotech industry. Oncologix Tech, Inc. seeks additional acquisitions of diagnostic and biotechnology opportunities to expand its portfolio. The firm's primary customers include partners, customers, vendors, and manufacturers within the medical device and biotech sectors. It targets opportunities in diagnostic and biotechnology fields through strategic acquisitions and partnerships. Oncologix Tech, Inc. focuses on executing agreements and conducting due diligence to secure new ventures in the biotech industry. Oncologix Tech, Inc. operates as a medical holding company with a focus on medical device products. It engages in reviewing licenses and sublicense agreements and conducts research on potential acquisitions. The company aims to expand its operations by acquiring diagnostic and biotechnology opportunities in the market. Oncologix Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncologix Tech stock

On Eulerpool you can find the complete historical development of EBIT per Share Oncologix Tech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Oncologix Tech

All Key Metrics — Oncologix Tech